SciSparc shares surge 28.34% intraday after announcing terms to acquire Xylo's endoscope systems and patents, planning to replicate successful licensing model in high-growth regions.

SciSparc surged 28.34% in intraday trading, driven by the company's announcement of a binding agreement to acquire Xylo Technologies' innovative endoscope system and medical camera patents, including intellectual property related to the single-use MUSE system. SciSparc plans to replicate the successful commercialization model, based on a $3 million upfront payment licensing agreement in the Greater China region in 2019, through distribution partnerships in high-growth regions such as North America, Europe, and Latin America to accelerate global market penetration.